These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18209601)

  • 1. Nonalcoholic fatty liver disease and OGTT.
    Uygur-Bayramiçli O; Sargin M
    J Clin Gastroenterol; 2008 Feb; 42(2):219. PubMed ID: 18209601
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?
    Sargin M; Uygur-Bayramiçli O; Sargin H; Orbay E; Yayla A
    J Clin Gastroenterol; 2003; 37(5):399-402. PubMed ID: 14564188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of latent diabetes in adults].
    Deuil R; Letailleur M
    Munch Med Wochenschr; 1968 Mar; 110(13):805-10. PubMed ID: 5755524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on fatty liver of various etiology and stage with reference to clinical aspects and functional diagnosis].
    Weise J; Rösch D
    Acta Hepatosplenol; 1971; 18(2):104-19. PubMed ID: 4101558
    [No Abstract]   [Full Text] [Related]  

  • 6. [The preventive value of supplementary diabetes screening by the detection of cases of latent diabetes mellitus].
    Hohenwallner W; Schweitzer F; Vinazzer G
    Wien Med Wochenschr; 1971 Jun; 121(25):525-7. PubMed ID: 5129949
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.
    Sonsuz A; Basaranoglu M; Ozbay G
    Am J Gastroenterol; 2000 May; 95(5):1370-1. PubMed ID: 10811364
    [No Abstract]   [Full Text] [Related]  

  • 8. Ready, set, stop! Preventing diabetes before it starts.
    Gebel E
    Diabetes Forecast; 2009 Feb; 62(2):40, 42. PubMed ID: 19326577
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nonalcoholic steatohepatitis].
    Dancygier H
    Dtsch Med Wochenschr; 2001 Aug; 126(33):930. PubMed ID: 11550669
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.
    Yilmaz Y; Ulukaya E; Dolar E
    Hepatology; 2009 Feb; 49(2):697; author reply 697. PubMed ID: 19035337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Common biochemical changes in obesity related liver diseases].
    Gao CF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):433. PubMed ID: 15268812
    [No Abstract]   [Full Text] [Related]  

  • 12. [Subclinical diabetes. Diagnosis and consequences].
    Gutsche H
    Med Klin; 1979 Jun; 74(22):843-9. PubMed ID: 381880
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.
    Cox-North PP
    J Am Board Fam Med; 2009; 22(3):339. PubMed ID: 19429743
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver].
    Zwimpfer J
    Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.
    Hwang ST; Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Rhee EJ; Oh KW; Lee WY; Jin W
    Intern Med J; 2010 Jun; 40(6):437-42. PubMed ID: 19460054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
    Yu AS; Keeffe EB
    Am J Gastroenterol; 2003 May; 98(5):955-6. PubMed ID: 12809814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selectrion of subjects with latent diabetes by discriminatory analysis of the value of certain hematic and instrumental indices].
    Meloni C; Marinoni A
    Policlinico Med; 1967 Aug; 74(4):206-17. PubMed ID: 5612867
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interpretation of hypertransaminasemia].
    Othmani S; Bahri M; Bahri M
    Tunis Med; 2002 May; 80(5):236-44. PubMed ID: 12534025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.